Article info
PDFClinical ethics
Familial genetic risks: how can we better navigate patient confidentiality and appropriate risk disclosure to relatives?
- Correspondence to Edward S Dove, School of Law, University of Edinburgh, Edinburgh EH8 9YL, UK; edward.dove{at}ed.ac.uk
Citation
Familial genetic risks: how can we better navigate patient confidentiality and appropriate risk disclosure to relatives?
Publication history
- Received October 26, 2018
- Revised March 7, 2019
- Accepted March 12, 2019
- First published May 23, 2019.
Online issue publication
August 27, 2019
Article Versions
- Previous version (23 May 2019).
- Previous version (7 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- Discovering misattributed paternity in genetic counselling: different ethical perspectives in two countries
- From proband to provider: is there an obligation to inform genetic relatives of actionable risks discovered through direct-to-consumer genetic testing?
- Disclosure of genetic information to relatives: balancing confidentiality and relatives’ interests
- Confidentiality in medicine: how far should doctors prioritise the confidentiality of the individual they are treating?
- Challenges of genetic testing in adolescents with cardiac arrhythmia syndromes
- Shared decision-making following disclosure of coronary heart disease genetic risk: results from a randomized clinical trial
- Development and evaluation of an online, patient-driven, family outreach intervention to facilitate sharing of genetic risk information in families with Lynch syndrome
- Healthcare professionals’ responsibility for informing relatives at risk of hereditary disease
- The right not to know: an autonomy based approach
- Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial